News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Emergent BioSolutions (EBS) to Webcast Presentation at Credit Suisse First Boston First Annual Antibody Day


4/29/2013 6:33:12 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the Credit Suisse First Annual Antibody Day in New York on May 10, 2013 at 9:30 AM Eastern. During the presentation, a member of the company's management team will provide an overview of the company’s lead clinical development candidate, the TRU-016 ADAPTIR™ (Modular Protein Technology) therapeutic, as well as a discussion of the company’s ADAPTIR platform and certain pre-clinical programs based on the ADAPTIR platform.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES